Nuveen LLC Acquires Shares of 686,907 Acadia Healthcare Company, Inc. $ACHC

Key Points

• Nuveen LLC has acquired 686,907 shares of Acadia Healthcare, valued at approximately $20.8 million, representing about 0.75% ownership in the company.
• Acadia Healthcare reported $0.83 earnings per share for the most recent quarter, exceeding analysts' expectations of $0.71, alongside a 9.2% increase in quarterly revenue year-over-year.
• Recent analyst ratings include upgrades to "hold" from Wall Street Zen and "outperform" from Raymond James, with a consensus target price of $40.77 for Acadia Healthcare shares.

Nuveen LLC bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 686,907 shares of the company's stock, valued at approximately $20,827,000. Nuveen LLC owned approximately 0.75% of Acadia Healthcare at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. UMB Bank n.a. boosted its position in shares of Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after purchasing an additional 755 shares in the last quarter. State of Wyoming bought a new position in Acadia Healthcare in the fourth quarter worth approximately $56,000. Covestor Ltd boosted its holdings in Acadia Healthcare by 56.0% in the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after acquiring an additional 812 shares in the last quarter. Aquatic Capital Management LLC bought a new position in Acadia Healthcare in the fourth quarter worth approximately $97,000. Finally, GAMMA Investing LLC boosted its holdings in Acadia Healthcare by 143.8% in the first quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock worth $176,000 after acquiring an additional 3,428 shares in the last quarter.

Acadia Healthcare Stock Performance

Shares of ACHC traded down $0.27 on Monday, reaching $22.17. 1,503,851 shares of the company's stock traded hands, compared to its average volume of 2,585,850. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. The stock has a market cap of $2.05 billion, a PE ratio of 14.68, a PEG ratio of 4.42 and a beta of 0.88. The stock's 50 day simple moving average is $21.94 and its two-hundred day simple moving average is $25.87. Acadia Healthcare Company, Inc. has a 52-week low of $17.13 and a 52-week high of $82.40.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. The company had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.Acadia Healthcare's revenue was up 9.2% on a year-over-year basis. During the same period last year, the business posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ACHC has been the topic of several recent research reports. UBS Group cut their price target on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a report on Thursday, August 7th. Cowen reiterated a "buy" rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Raymond James Financial reissued an "outperform" rating and issued a $26.00 price objective (down from $40.00) on shares of Acadia Healthcare in a research note on Thursday, August 14th. Finally, Barclays lowered their price objective on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Nine analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $40.77.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.